U.S. CDMRP – Peer Reviewed Medical Research Program| Research Funding
Event details
| Date | 16.07.2026 |
| Category | Call for proposal |
| Event Language | English |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the 2026 Peer Reviewed Medical Research Program (PRMRP). Several award programs are available:
Funding:
Clinical Trial Award: $6M-$20M
Discovery Award: max. $385K
Impact Award: $2.8M-$3.6M
Lifestyle and Applied Health Research Award: max. $4.2M
Platform Clinical Translation Award: max. $15M
Research Advancement Award: max. $1.4M
Technology/Therapeutic Development Award: max. $5.6M
Note: Cost caps are total costs (direct plus indirect costs). In accordance with EPFL guidelines, budgets should include a 20% overhead, and the total budget must remain within the grant’s maximum allowable funding
Duration:
Clinical Trial Award: 4 years
Discovery Award: 2 years
Impact Award: 4 years
Lifestyle and Applied Health Research Award: 4 years
Platform Clinical Translation Award: 4 years
Research Advancement Award: 4 years
Technology/Therapeutic Development Award: 4 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Independent investigators at all career levels are eligible.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace.
Pre-Application Deadline:
Full Application Deadline:
Further information:
- The Clinical Trial Award supports the rapid execution and analysis of clinical trials with the potential to have a significant impact on the treatment or management of a disease or condition addressed in one of the Topic Areas and one of the Strategic Goals. Proposed projects may range from small proof-of-concept trials through large-scale, definitive trials.
- The Discovery Award supports innovative, untested, non-incremental, high risk/potentially high-reward research that will provide new insights, paradigms, technologies, or applications with impact on one of the Topic Areas and one of the Strategic Goals.
- The Impact Award supports applied research, defined as use-inspired and practice-oriented science that brings together outcomes from basic research and insights from the real-world environment to foster clinical applicability. Applications should demonstrate the potential to make a near-term, major impact on one of the Topic Areas and one of the Strategic Goals.
- The Lifestyle and Applied Health Research Award supports clinical research and/or clinical trials using a combination of scientific disciplines, including occupational science, psychology, psychometrics, biostatistics and epidemiology, surveillance, implementation science, and population health. Applications must address and provide a solution to one of the Topic Areas and one of the Strategic Goals.
- The Platform Clinical Translation Award supports the translational development and/or early phase clinical trials for broadly applicable clinical technologies that will address urgent and complex needs related to two Topic Areas. Applications must address one of the Strategic Goals.
- The Research Advancement Award supports fundamental research studies that will make an important contribution towards research, patient care, and/or quality of life for a disease or condition related to one of the Topic Areas and one of the Strategic Goals.
- The Technology/Therapeutic Development Award supports the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, for a disease or condition related to one of the Topic Areas and one of the Strategic Goals. Applications must describe product-oriented research. Products can be tangible items, such as drugs or devices, or can be knowledge products, such as clinical decision-making tools or practice guidelines.
Funding:
Clinical Trial Award: $6M-$20M
Discovery Award: max. $385K
Impact Award: $2.8M-$3.6M
Lifestyle and Applied Health Research Award: max. $4.2M
Platform Clinical Translation Award: max. $15M
Research Advancement Award: max. $1.4M
Technology/Therapeutic Development Award: max. $5.6M
Note: Cost caps are total costs (direct plus indirect costs). In accordance with EPFL guidelines, budgets should include a 20% overhead, and the total budget must remain within the grant’s maximum allowable funding
Duration:
Clinical Trial Award: 4 years
Discovery Award: 2 years
Impact Award: 4 years
Lifestyle and Applied Health Research Award: 4 years
Platform Clinical Translation Award: 4 years
Research Advancement Award: 4 years
Technology/Therapeutic Development Award: 4 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Independent investigators at all career levels are eligible.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace.
Pre-Application Deadline:
- 16 July 2026, 5:00 p.m. Eastern time
- Discovery Award
- Research Advancement Award
- 23 July 2026, 5:00 p.m. Eastern time
- Clinical Trial Award
- Impact Award
- Lifestyle and Applied Health Research Award
- Platform Clinical Translation Award
- Technology/Therapeutic Development Award
Full Application Deadline:
- 30 July 2026, 11:59 p.m. Eastern time
- Discovery Award
- Research Advancement Award
- 06 August 2026, 11:59 p.m. Eastern time
- Impact Award
- Lifestyle and Applied Health Research Award
- Technology/Therapeutic Development Award
- 22 September 2026, 11:59 p.m. Eastern time
- Clinical Trial Award
- Platform Clinical Translation Award
Further information:
- To find the full program announcements and to start your pre-application see here
- A useful summary of each call can be found here
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
- Grants.gov Funding Opportunity Numbers:
- Clinical Trial Award: HT942526PRMRPCTA
- Discovery Award: HT942526PRMRPDA
- Impact Award: HT942526PRMRPIPA
- Lifestyle and Applied Health Research Award: HT942526PRMRPLAHRA
- Platform Clinical Translation Award: HT942526PRMRPPCTA
- Research Advancement Award: HT942526PRMRPRAA
- Technology/Therapeutic Development Award: HT942526PRMRPTTDA
Practical information
- General public
- Free